IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Molecular and Cellular Oncology

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on June 27, 2025

Impact Score

2024-2025

1.38

h-Index

2024-2025

 37

Rank

2024-2025

 12860

SJR

2024-2025

 0.44

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Molecular and Cellular Oncology
Abbreviation Mol. Cell. Oncol.
Publication Type Journal
Subject Area, Categories, Scope Molecular Medicine (Q3); Cancer Research (Q4)
h-index 37
Overall Rank/Ranking 12860
SCImago Journal Rank (SJR) 0.44
Impact Score 1.38
Publisher Taylor and Francis Ltd.
Country United Kingdom
ISSN 23723556
Best Quartile Q3
Coverage History 2014-2024




About Molecular and Cellular Oncology


Molecular and Cellular Oncology is a journal covering the technologies/fields/categories related to Molecular Medicine (Q3); Cancer Research (Q4). It is published by Taylor and Francis Ltd.. The overall rank of Molecular and Cellular Oncology is 12860. According to SCImago Journal Rank (SJR), this journal is ranked 0.44. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 37. The best quartile for this journal is Q3.

The ISSN of Molecular and Cellular Oncology journal is 23723556. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Molecular and Cellular Oncology is cited by a total of 109 articles during the last 3 years (Preceding 2024).


Molecular and Cellular Oncology Impact IF 2024-2025


The Impact IF 2024 of Molecular and Cellular Oncology is 1.38, which is computed in 2025 as per its definition. Molecular and Cellular Oncology IF is increased by a factor of 0.5 and approximate percentage change is 56.82% when compared to preceding year 2023, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Molecular and Cellular Oncology Impact IF 2025 Prediction


Impact IF 2024 of Molecular and Cellular Oncology is 1.38. If the same upward trend persists, Impact IF may rise in 2025 as well.


Impact IF Trend


Year wise Impact IF of Molecular and Cellular Oncology. Based on Scopus data.


Year Impact IF
2025/2026 Coming Soon
2024 1.38
2023 0.88
2022 1.04
2021 1.34
2020 1.27
2019 1.01
2018 1.31
2017 1.51
2016 0.55
2015 0.26
2014 0.00

Molecular and Cellular Oncology h-index


  Table Setting

Molecular and Cellular Oncology has an h-index of 37. It means 37 articles of this journal have more than 37 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Molecular and Cellular Oncology ISSN


The ISSN of Molecular and Cellular Oncology is 23723556. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Molecular and Cellular Oncology Rank and SCImago Journal Rank (SJR)


The overall rank of Molecular and Cellular Oncology is 12860. According to SCImago Journal Rank (SJR), this journal is ranked 0.44. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Molecular and Cellular Oncology by Year


Year SJR
2025/2026 Coming Soon
2024 0.44
2023 0.471
2022 0.436
2021 0.501
2020 0.696
2019 0.580
2018 0.877
2017
2016
2015
2014

Ranking of Molecular and Cellular Oncology by Year


Year Ranking
2025/2026 Coming Soon
2024 12860
2023 11406
2022 11686
2021 9998
2020 7164
2019 8547
2018 5237
2017 34180
2016 33688
2015 33220
2014 32537

Molecular and Cellular Oncology Publisher


Table Setting

Molecular and Cellular Oncology is published by Taylor and Francis Ltd.. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2014-2024. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Molecular and Cellular Oncology is Mol. Cell. Oncol.. This abbreviation ('Mol. Cell. Oncol.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Molecular and Cellular Oncology


If your research field is/are related to Molecular Medicine (Q3); Cancer Research (Q4), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Molecular and Cellular Oncology?

Molecular and Cellular Oncology latest impact IF is 1.38. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 1.51 (2017) and 0.00 (2014), respectively, in the last 11 years. Moreover, its average IS is 0.96 in the previous 11 years.


What's the SCImago Journal Rank (SJR) of the Molecular and Cellular Oncology?

The Molecular and Cellular Oncology has an SJR (SCImago Journal Rank) of 0.44, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 0.877 in 2018 and the lowest being in 2017. Furthermore, the average SJR of the Molecular and Cellular Oncology over the previous 11-year period stands at 0.96.


What's the latest h-index of the Molecular and Cellular Oncology?

The latest h-index of the Molecular and Cellular Oncology is 37.


Who's the publisher of the Molecular and Cellular Oncology?

The Molecular and Cellular Oncology is published by the Taylor and Francis Ltd., with its country of publication being the United Kingdom.


What's the current ranking of the Molecular and Cellular Oncology?

The Molecular and Cellular Oncology is currently ranked 12860 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 5237 in 2018 and its lowest position of 34180 in 2017.


What's the abbreviation or short name for the Molecular and Cellular Oncology?

The standard ISO4 abbreviation for the Molecular and Cellular Oncology is Mol. Cell. Oncol..


Is the "Molecular and Cellular Oncology" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Molecular and Cellular Oncology is classified as a journal that the Taylor and Francis Ltd. publishes.


What's the scope or major areas of the Molecular and Cellular Oncology?

The Molecular and Cellular Oncology encompasses the following areas:

  • Molecular Medicine
  • Cancer Research

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Molecular and Cellular Oncology?

The Molecular and Cellular Oncology is assigned the following International Standard Serial Numbers (ISSN): 23723556.


What's the best quartile of the Molecular and Cellular Oncology?

The best quartile for the Molecular and Cellular Oncology is Q3 (2024).


What's the coverage history of the Molecular and Cellular Oncology?

The Molecular and Cellular Oncology coverage history can be summarized as follows: 2014-2024.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
CESifo Economic Studies journal 17776 Oxford University Press 36 0.89
Journal of Business Finance and Accounting journal 3244 Wiley-Blackwell Publishing Ltd 96 3.34
Materials Research journal 15597 Universidade Federal de Sao Carlos 75 1.40
World Englishes journal 7267 Wiley-Blackwell 68 2.38
Canadian Journal of Education journal 15557 Canadian Society for the Study of Education (CSSE) 46 0.80
Journal, Indian Academy of Clinical Medicine journal 28559 Indian Academy of Clinical Medicine 16 0.10
Tekstilec trade journal 17340 University of Ljubljana Press 16 1.29
Sapporo Medical Journal journal 29756 Sapporo Medical University 3 0.00
Indian Phytopathology journal 16772 Springer 20 0.91
Archiv fur Geflugelkunde journal 28770 Verlag Eugen Ulmer 30 0.00

Check complete list




Year wise Impact Score (IS) of Molecular and Cellular Oncology

Impact Score Table

Year Impact Score (IS)
2025/2026 Coming Soon
2024 1.38
2023 0.88
2022 1.04
2021 1.34
2020 1.27
2019 1.01
2018 1.31
2017 1.51
2016 0.55
2015 0.26
2014 0.00



Top Journals/Conferences in Molecular Medicine

Nature Biotechnology
Nature Research | United Kingdom

Cell Stem Cell
Cell Press | United States

Molecular Cancer
BioMed Central Ltd | United Kingdom

Pharmacological Reviews
Elsevier Inc. | United States

Genome Medicine
BioMed Central Ltd | United Kingdom

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

Molecular Therapy
Cell Press | United States

Experimental and Molecular Medicine
Springer Nature | United Kingdom

Trends in Molecular Medicine
Elsevier Ltd | United Kingdom

EMBO Molecular Medicine
Springer Science and Business Media Deutschland GmbH | United Kingdom

See All

Top Journals/Conferences in Cancer Research

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Signal Transduction and Targeted Therapy
Springer Nature | United Kingdom

Nature Cancer
Nature Research | United States

Journal of Clinical Oncology
Lippincott Williams and Wilkins | United States

Journal of Hematology and Oncology
BioMed Central Ltd | United Kingdom

Molecular Cancer
BioMed Central Ltd | United Kingdom

JAMA Oncology
American Medical Association | United States

Cell Host and Microbe
Cell Press | United States

Neuro-Oncology
Oxford University Press | United Kingdom

See All